Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

February 01, 1989; Volume 248,Issue 2
  • You have access
    Canine pulmonary artery contains a homogeneous population of alpha-1 adrenoceptors.
    J R Docherty and R R Ruffolo
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 479-483;
  • You have access
    Effect of the thromboxane A2 receptor antagonist SQ 30,741 on ultimate myocardial infarct size, reperfusion injury and coronary flow reserve.
    G J Grover and W A Schumacher
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 484-491;
  • You have access
    Stereoselectivity of styrene oxidation in microsomes and in purified cytochrome P-450 enzymes from rat liver.
    G L Foureman, C Harris, F P Guengerich and J R Bend
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 492-497;
  • You have access
    Toxicity of the HMG-coenzyme A reductase inhibitor, lovastatin, to rabbits.
    D J Kornbrust, J S MacDonald, C P Peter, D M Duchai, R J Stubbs, J I Germershausen and A W Alberts
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 498-505;
  • You have access
    Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect.
    D D Chow, H E Essien, M M Padki and K J Hwang
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 506-513;
  • You have access
    K+ channel and adenylate cyclase involvement in regulation of Ca2+-evoked release of [3H]dopamine from synaptosomes.
    J F Bowyer and N Weiner
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 514-520;
  • You have access
    Effects of acute and chronic clozapine and haloperidol on in vitro release of acetylcholine and dopamine from striatum and nucleus accumbens.
    D R Compton and K M Johnson
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 521-530;
  • You have access
    Uptake of nephrotoxic S-conjugates by isolated rat renal proximal tubular cells.
    L H Lash and M W Anders
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 531-537;
  • You have access
    Glucose utilization in the rat brain during chronic morphine treatment and naloxone-precipitated morphine withdrawal.
    A S Kimes and E D London
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 538-545;
  • You have access
    Environmental determinants of enhanced sensitivity to the behavioral effects of naltrexone.
    P H Warren and W H Morse
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 546-551;
  • You have access
    Electrophysiological effects of ACC-9358, a novel class I antiarrhythmic agent, on isolated canine Purkinje fibers and ventricular muscle.
    B S Brown
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 552-558;
  • You have access
    Platelet-activating factor-induced phosphoinositide metabolism in differentiated U-937 cells in culture.
    G Barzaghi, H M Sarau and S Mong
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 559-566;
  • You have access
    Colonic absorption of insulin: an in vitro and in vivo evaluation.
    J A Atchison, W E Grizzle and D J Pillion
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 567-572;
  • You have access
    Evidence for muscarinic inhibitory neurotransmission in rodent small intestine.
    T V Nowak, B Harrington and J H Kalbfleisch
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 573-580;
  • You have access
    Kinetic and pharmacologic analysis of [3H]leukotriene E4 binding to receptors on guinea pig lung membranes: evidence for selective binding to a subset of leukotriene D4 receptors.
    D Aharony, C A Catanese and R C Falcone
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 581-588;
  • You have access
    Xanthine effects on renal proximal tubular function and cyclic AMP metabolism.
    R Coulson and S J Scheinman
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 589-595;
  • You have access
    Mechanisms of central hemodynamic and sympathetic regulation by mu opioid receptors: effects of dermorphin in the conscious rat.
    A L Sirén, P Paakkari, D S Goldstein and G Feuerstein
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 596-604;
  • You have access
    Kinetics of chlorpromazine block of sodium channels in single guinea pig cardiac myocytes.
    N Ogata, M Nishimura and T Narahashi
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 605-613;
  • You have access
    Uptake and hormonally induced hydrolysis of [3H]phosphatidyl choline in the isolated rabbit heart.
    M T Weis and K U Malik
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 614-620;
  • You have access
    Pharmacological characterization of rat retinal dopamine receptors.
    Z X Qu, R Fertel, N H Neff and M Hadjiconstantinou
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 621-625;
  • You have access
    Castration blocks chronic sulpiride-induced desensitization of striatal D1 receptor-stimulated adenylate cyclase activity in male rats.
    T Ryan-Jastrow and M E Gnegy
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 626-631;
  • You have access
    Cardiac hypertrophy induced by thyroid hormone is independent of loading conditions and beta adrenoceptor blockade.
    J B Bedotto, R G Gay, S D Graham, E Morkin and S Goldman
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 632-636;
  • You have access
    Studies on inhibition of angiotensin II receptors in rabbit adrenal and aorta.
    R G Pendleton, G Gessner and E Horner
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 637-643;
  • You have access
    Effects of low extracellular chloride on dopamine release and the dopamine transporter.
    P A Diliberto, R A Jeffs and L X Cubeddu
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 644-653;
  • You have access
    Contrasting effects of verapamil and nifedipine on pH of ischemic myocardium in the dog.
    Y M Ro, D R Markle, S R Goldstein, E Speir, R Greene, K Steadman, R Aamodt, S E Epstein and R E Patterson
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 654-660;
  • You have access
    Pharmacological characterization of the M1 muscarinic receptors expressed in murine fibroblast B82 cells.
    L Mei, J Lai, W R Roeske, C M Fraser, J C Venter and H I Yamamura
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 661-670;
  • You have access
    Effect of aromatic fluorine substitution on the alpha and beta adrenoceptor-mediated effects of 3,4-dihydroxytolazoline in the pithed rat.
    A J Nichols, A Hamada, A Adejare, D D Miller, P N Patil and R R Ruffolo
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 671-676;
  • You have access
    [Arg1-D-Phe7]-substituted bradykinin analogs inhibit bradykinin- and vasopressin-induced contractions of uterine smooth muscle.
    S G Farmer, R M Burch, C J Dehaas, J Togo and L R Steranka
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 677-681;
  • You have access
    Cholinergic stimulation of phosphoinositide hydrolysis in renal medullary collecting duct cells.
    S McArdle and L C Garg
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 682-686;
  • You have access
    Interactions of light and sodium nitrite in producing relaxation of rabbit aorta.
    K Matsunaga and R F Furchgott
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 687-695;
  • You have access
    Block of 45Ca uptake into synaptosomes by methylmercury: Ca++- and Na+-dependence.
    T J Shafer and W D Atchison
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 696-702;
  • You have access
    Influence of stimulators and inhibitors of cyclic nucleotides on lower esophageal sphincter.
    S Rattan and C Moummi
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 703-709;
  • You have access
    Effects of Ca++ on [3H]diltiazem binding and its allosteric interaction with dihydropyridine calcium channel binding sites in the rat cortex.
    H Schoemaker and S Z Langer
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 710-715;
  • You have access
    Effect of ouabain on the concentration of free cytosolic Ca++ and on contractility in cultured rat cardiac myocytes.
    H Hallaq, Y Hasin, R Fixler and Y Eilam
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 716-721;
  • You have access
    Characterization of L-glutamate action on the release of endogenous dopamine from the rat caudate-putamen.
    D W Clow and K Jhamandas
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 722-728;
  • You have access
    Veratrine-induced decrease of (Na+ + K+)-adenosine triphosphatase activity in rat brain slices.
    T Matsuda and H Iwata
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 729-735;
  • You have access
    An investigation of the effects of intravenous injection of the 5-hydroxytryptamine 2 receptor antagonists ketanserin and LY 53857 on blood pressure in anesthetized spontaneously hypertensive rats.
    J R Docherty
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 736-740;
  • You have access
    Tertatolol increases glomerular filtration and urinary sodium in anesthetized rats.
    G E Plante, C Prévost, P Sirois, C Rochat and J F Prost
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 741-746;
  • You have access
    Pharmacokinetic patterns of repeated administration of antidepressants in animals. II. Their relevance in a study of the influence of clomipramine on morphine analgesia in mice.
    J Fialip, H Marty, M C Makambila, M A Civiale and A Eschalier
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 747-751;
  • You have access
    Effects of alpha adrenoceptor blockade on renal nerve stimulation-induced norepinephrine release and vasoconstriction in the dog kidney.
    H Hisa, S Araki, Y Tomura, Y Hayashi and S Satoh
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 752-757;
  • You have access
    Regulation of rat uterine steroid receptors by nomegestrol acetate, a new 19-nor-progesterone derivative.
    J Botella, I Duc, R Delansorne, J Paris and B Lahlou
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 758-761;
  • You have access
    Nitroglycerin-induced tolerance affects multiple sites in the organic nitrate bioconversion cascade.
    P J Henry, J D Horowitz and W J Louis
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 762-768;
  • You have access
    Vasorelaxing effects of prostaglandin I2 on the canine basilar and coronary arteries.
    H Shirahase, H Usui, K Manabe, K Kurahashi and M Fujiwara
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 769-773;
  • You have access
    Relaxant effect of N-formyl-methionyl-leucyl-phenylalanine on rabbit vascular strips.
    C Laplante, B Tremblay and F Marceau
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 774-780;
  • You have access
    Effect of alpha-1-acid glycoprotein, albumin and palmitic acid on the brain and salivary gland extraction of warfarin in rats.
    S Urien, D Morin and J P Tillement
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 781-785;
  • You have access
    Effects of acute and chronic prenatal nicotine treatment on central catecholamine systems of male and female rat fetuses and offspring.
    U Ribary and W Lichtensteiger
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 786-792;
  • You have access
    Stimulation of gastric alkaline secretion by histamine in rats: possible involvement of histamine H2-receptors and endogenous prostaglandins.
    H Nishiwaki, K Takeuchi, M Okada, H Tanaka and S Okabe
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 793-798;
  • You have access
    Possible mechanism for the inhibition of gastric (H+ + K+)-adenosine triphosphatase by the proton pump inhibitor AG-1749.
    H Nagaya, H Satoh, K Kubo and Y Maki
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 799-805;
  • You have access
    Antisecretory and antiulcer activities of a novel proton pump inhibitor AG-1749 in dogs and rats.
    H Satoh, N Inatomi, H Nagaya, I Inada, A Nohara, N Nakamura and Y Maki
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 806-815;
  • You have access
    Involvement of calcitonin gene-related peptide in the positive chronotropic and inotropic effects of piperine and development of cross-tachyphylaxis between piperine and capsaicin in the isolated rat atria.
    T Miyauchi, T Ishikawa, Y Sugishita, A Saito and K Goto
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 816-824;
  • You have access
    Effects of continuous infusion of cholinergic drugs on memory impairment in rats with basal forebrain lesions.
    M Miyamoto, S Narumi, A Nagaoka and J T Coyle
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 825-835;
  • You have access
    Role of sulfhydryls in mucosal injury caused by ethanol: relation to microvascular permeability, gastric motility and cytoprotection.
    K Takeuchi, M Okada, H Niida and S Okabe
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 836-841;
  • You have access
    Toxic effects of potential environmental neurotoxins related to 1-methyl-4-phenylpyridinium on cultured rat dopaminergic neurons.
    P P Michel, B K Dandapani, J Sanchez-Ramos, S Efange, B C Pressman and F Hefti
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 842-850;
  • You have access
    Effect of activation of central nervous system serotonin 1A receptors on cardiorespiratory function.
    R A Gillis, K J Hill, J S Kirby, J A Quest, P Hamosh, W P Norman and K J Kellar
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 851-857;
  • You have access
    Striatal tachykinin gene expression regulated by interaction of D-1 and D-2 dopamine receptors.
    D M Haverstick, A Rubenstein and M J Bannon
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 858-862;
  • You have access
    Drug interaction with gamma-aminobutyric acid/benzodiazepine receptors at the ventral surface of the medulla results in pronounced changes in cardiorespiratory activity.
    R A Gillis, I J Namath, C Easington, T P Abrahams, A Guidotti, J A Quest, P Hamosh and A M Taveira da Silva
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 863-870;
  • You have access
    Mechanism of protective effects of Ca++ channel blockers on energy deprivation contracture in cultured ventricular myocytes.
    O Kohmoto and W H Barry
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 871-878;
  • You have access
    Responses of substantia nigra pars reticulata neurons to benzodiazepine ligands after acute and prolonged diazepam exposure. I. Modulation of gamma-aminobutyric acid sensitivity.
    M A Wilson and D W Gallager
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 879-885;
  • You have access
    Responses of substantia nigra pars reticulata neurons to benzodiazepine ligands after acute and prolonged diazepam exposure. II. Modulation of firing rate.
    M A Wilson and D W Gallager
    Journal of Pharmacology and Experimental Therapeutics February 1989, 248 (2) 886-891;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 248, Issue 2
1 Feb 1989
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Cited
  • Most Read
Loading
  • Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians.
  • Functional Selectivity and Classical Concepts of Quantitative Pharmacology
  • Abl Protein-Tyrosine Kinase Inhibitor STI571 Inhibits In Vitro Signal Transduction Mediated by c-Kit and Platelet-Derived Growth Factor Receptors
  • The Prediction of Human Pharmacokinetic Parameters from Preclinical and In Vitro Metabolism Data
  • A METHOD FOR DETERMINING LOSS OF PAIN SENSATION
More...
Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics